Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Al-Rawas, O. A.
Right arrow Articles by Wheatley, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Al-Rawas, O. A.
Right arrow Articles by Wheatley, D. J.
(Chest. 2000;118:1661-1670.)
© 2000 American College of Chest Physicians

Exercise Intolerance Following Heart Transplantation*

The Role of Pulmonary Diffusing Capacity Impairment

Omar A. Al-Rawas, PhD; Roger Carter, MSc; Robin D. Stevenson, MD; Sureen K. Naik, PhD and David J. Wheatley, MD

* From the Department of Respiratory Medicine (Drs. Al-Rawas and Stevenson, and Mr. Carter) and the University Department of Cardiac Surgery (Drs. Naik and Wheatley), Glasgow Royal Infirmary, Glasgow, Scotland, UK.

Correspondence to: Omar A. Al-Rawas, Department of Medicine, College of Medicine, Sultan Qaboos University, PO Box 35, Postal Code 123, Muscat, Sultanate of Oman; e-mail: orawas{at}squ.edu.om

Study objectives: Although impairment of the diffusing capacity of the lung for carbon monoxide (DLCO) in heart transplant recipients is well-documented, there are limited data on its impact on exercise capacity in these patients. The aim of this study was to determine the effect of DLCO reduction on exercise capacity in heart transplant recipients.

Design: Descriptive cohort study.

Setting: A regional cardiopulmonary transplant center.

Participants: Twenty-six heart transplant recipients who were studied before and after transplantation compared with 26 healthy volunteers.

Measurements: Spirometry and static lung volumes were measured using body plethysmography, DLCO was measured using the single-breath technique, and progressive cardiopulmonary exercise was performed using a bicycle ergometer, continuous transcutaneous blood gas monitoring, and on-line analysis of minute ventilation, oxygen uptake (O2), and carbon dioxide production.

Results: Before transplantation, the mean percent predicted for hemoglobin-corrected DLCO was reduced in patients (73.2%) compared to healthy control subjects (98.8%; p < 0.001) and declined significantly after transplantation (60.1%; p < 0.05). Although the mean maximal symptom-limited O2 (O2max) increased after transplantation (increase, 41.3 to 48.6% of predicted; p < 0.05), it remained substantially lower than normal (92.9%; p < 0.001). There was a significant correlation between DLCO and O2max after transplantation (r = 0.61; p = 0.001), but not before transplantation (r = 0.09; p = 0.66). DLCO was also inversely correlated with other respiratory responses to exercise, including the following: the ventilatory response to exercise (r = -0.44; p < 0.05); dead space to tidal volume ratio (r = -43; p < 0.05); and the alveolar-arterial oxygen gradient (r = -0.45; p < 0.05), but there was no correlation between any of these variables and DLCO before transplantation.

Conclusion: DLCO reduction after heart transplantation appears to represent persistent gas exchange impairment and contributes to exercise limitation in heart transplant recipients.

Key Words: cardiopulmonary exercise testing • exercise capacity • heart transplantation • pulmonary diffusing capacity • pulmonary function • pulmonary gas exchange




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
W. C. Levy and I. B. Hirsch
Diabetes and heart failure: is insulin therapy the answer?
J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1051 - 1053.
[Full Text] [PDF]


Home page
ChestHome page
M. Guazzi
Alveolar-Capillary Membrane Dysfunction in Heart Failure: Evidence of a Pathophysiologic Role
Chest, September 1, 2003; 124(3): 1090 - 1102.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. Ewert, C. Opitz, R. Wensel, M. Dandel, S. Mutze, and P. Reinke
Abnormalities of Pulmonary Diffusion Capacity in Long-term Survivors After Kidney Transplantation*
Chest, August 1, 2002; 122(2): 639 - 644.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American College of Chest Physicians.